Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Chinese researchers disclose SOS1 inhibitors

Jan. 3, 2022

Medshine Discovery patents new GLP-1 receptor agonists

Jan. 3, 2022

New PD-1/PD-L1 interaction inhibitors identified at Kainos Medicine

Dec. 31, 2021

Kinnate Biopharma discovers FGFR inhibitors

Dec. 31, 2021

CSPC Zhongqi Pharmaceutical Technology patents PTPN11 inhibitors

Dec. 31, 2021

New CDK7 inhibitors presented by ScinnoHub Pharmaceutical

Dec. 31, 2021

Medshine Discovery identifies new NLRP3 inflammasome inhibitors

Dec. 31, 2021

Merck & Co. divulges dual Toll-like receptor 7/8 agonists

Dec. 30, 2021

New psychosine receptor modulators patented by Pathios Therapeutics

Dec. 30, 2021

GB005 discovers Bruton tyrosine kinase inhibitors

Dec. 30, 2021

Popular Stories

Today's news in brief
BioWorld
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...